How onclive.com Get Unbelievable Success With Landing Page
As we known，Landing page is an essential part of marketing campaign because it has the unique ability to convert a stranger into a qualified lead. But how can we increase the ROI? How to find landing page copy and image for inspiration? How to know competitors’ advertising strategy?
Fortunately, LandingSpy can help you successfully solve the problems above. LandingSpy is the best landing page software. It tracks the onclive.com ads, and analyzes the landing page data of the ads. Its landing page link is onclive.com.
So, how onclive.com get unbelievable success with landing page?
1.onclive.com’s ad landing page basic information
Landing Page Images:
Title：Dr. Maloney on the Value of CAR T Cells in Relapsed/Refractory Aggressive Lymphomas
Description：David G. Maloney, MD, PhD, discusses the value of chimeric antigen receptor T-cell therapy in patients with relapsed/refractory aggressive lymphomas.
Advertising Platform：Facebook
Period：5
Start Time and End Time：2020-04-07~2020-04-12
Landing Type：Other
Language & Countries：N/A&N/A
Related Landing Pages：8
Final URL：onclive.com
The Number of Outgoings Link ：0
2. Free related landing pages analytics
In addition to the above ad landing pages, onclive.com recently launched related landing pages with a total number of 8. The main advertising platforms of these related ad landing pages are Facebook、Facebook etc. These ad landing pages include some AB-tested pages. After the final verification, onclive.com has placed a lot of ads by using the most effective ad landing pages.
LandingSpy performed basic data analysis on these related landing pages and selected the top 3 that performed best.
| 1st | 2nd | 3rd | |
| Title | Emerging Agents for Treatment of HCC | The National LymphoCare Study in Follicular Lymphoma | Novel-Based Approaches in Treating GVHD |
| Description | Ghassan K. Abou-Alfa, MD; Richard S. Finn, MD; Masatoshi Kudo, MD, PhD; and Arndt Vogel, MD, comment on the emerging agents and combinations that appear promising for treatment of hepatocellular carcinoma. | An overview of the National LymphoCare Study in follicular lymphoma and insight regarding early progression of disease based on observations noted by the trial’s data. | Dr Antin outlines different novel-based approaches for graft-versus-host disease including alpha-1 antitrypsin and monoclonal antibodies. |
| Advertising Platform | |||
| Period | 159 | 113 | 84 |
| Start Time and End Time | 2019-11-05~2020-04-12 | 2020-01-24~2020-05-16 | 2020-01-19~2020-04-12 |
| Language & Countries | N/A&N/A | N/A&N/A | N/A&N/A |
The above is the detailed information of the 3 landing pages that advertisers onclive.com have performed best in the recent past. After many A/B tests, these ad landing pages proved to be the most effective. So what do they have in common? By comprehensively analyzing the various data of these landing pages, we can summarize some rules to discover the secrets of high-converting ad landing pages.
1) Title analysis
- The number of words in the title is usually 5-10 words, and the words are as simple as possible.
- Core keywords and important content are put forward.
- Declarative Affirmative Sentences
- Titles with numbers are 36% more likely to be clicked by users than without numbers.
In fact, I prefer the title “Emerging Agents for Treatment of HCC” better than “The National LymphoCare Study in Follicular Lymphoma”.
2) Description analysis
Copywriting tests the ability of the writer to perceive the user’s psychology. What we need to do is to stand in the user’s perspective, understand the needs of the users, and introduce your products from what they want to know.
Obviously, the descriptions of these related landing pages all conform to the above rules. For example:
- Ghassan K. Abou-Alfa, MD; Richard S. Finn, MD; Masatoshi Kudo, MD, PhD; and Arndt Vogel, MD, comment on the emerging agents and combinations that appear promising for treatment of hepatocellular carcinoma.
- An overview of the National LymphoCare Study in follicular lymphoma and insight regarding early progression of disease based on observations noted by the trial’s data.
- Dr Antin outlines different novel-based approaches for graft-versus-host disease including alpha-1 antitrypsin and monoclonal antibodies.
If you want to know the description of other landing pages with the best performance in the past 90 days, you can use LandingSpy (landingspy.com) to filter and query.
3) Advertising platform
From the above table, we can see that the advertiser onclive.com’s recent platform for advertising is mainly Facebook.
4) Advertising schedule
Advertisers onclive.com have recently advertised at 2019-11-05~2020-04-12、2020-01-24~2020-05-16、2020-01-19~2020-04-12. The periods the ads continue to run are 159 days, 113 days, and 84 days.
Different industries and different platforms have different effective times when advertising. When scheduling ads, we should check the competitors’ advertising strategies in advance, not only to avoid overlapping with their high-frequency advertising time but also not to miss the best period for advertising in the industry.
In conclusion: The above is a free landing page analytics report about onclive.com. Doing a good job in advertising is a long-term accumulation process. In this process, we can use the bestlanding page software to find excellent landing page copy and landing page images for reference. At the same time, understand the competitors’ advertising strategies in advance, then adjust and test your advertising plans in a timely manner.
3. Related landing page report
If you want to check the relevant analysis of other landing page related to onclive.com, you can click the app name below to view related reports.